The effect of combinations of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against clinical isolates of Escherichia coli (11 strains) and Klebsiella pneumoniae (12 strains) was examined by using a microdilution checkerboard technique. All isolates were susceptible to each antimicrobial agent. Synergism, defined as at least a 2-log2-dilution lowering of the minimal inhibitory concentration of either antibiotic in the combination compared with the minimal inhibitory concentration of the antibiotic alone, was observed with 15 of 23 (65%) isolates tested against trimethoprim and gentamicin and 14 of 23 (61%) isolates tested against sulfamethoxazole-trimethoprim and gentamicin. A 3-log2-dilution lowering of the minimnal inhibitory concentration of either antibiotic was observed in 7 of 23 (30%) trimethoprim and gentamicin trials and 3 of 23 (13%) sulfamethoxazole-trimethoprim and gentamicin trials. Antagonism was observed in 3 of 46 combination trials and only with strains of K. pneumoniae.
The synergism of trimethoprim and sulfamethoxazole against a variety of gram-negative bacilli has been well documented. Recently, trimethoprim has been found to act synergistically when combined with rifampin and polymyxin (2, 3, 6) . The combination of an aminoglycoside with trimethoprim alone has been evaluated in only a few previous studies (1, 5) , and none has assessed the interaction of sulfamethoxazole-trimethoprin, the currently available trimethoprim preparation in the United States, with an aminoglycoside. The present study examines the interaction of trimethoprim alone and sulfamethoxazole-trimethoprim with gentamicin against strains of Escherichia coli and Klebsiella pneumoniae. Organisms were subcultured into Mueller-Hinton broth, grown to a turbidity equivalent to that of a McFarland no. 1 standard, and diluted in the appropriate broth so that inocula contained between 0.9 x 105 and 2.0 x 105 colony-forming units per ml (determined by pour plates). Each microtiter well received 0.05 ml of inoculum. The plates were sealed, shaken, and incubated at 37°C for 16 to 20 h. Inhibition was defined as absence of visible turbidity. Duplicate MIC values for each drug were obtained. If the values were discrepant, the higher of the two was chosen as the MIC.
MATERIALS AND METHODS
The qualitative response to the combination was defined by the observed difference between the MIC of a drug tested alone and in combination. If the MIC of either drug in the combination was at least 2 log2 dilutions lower than the MIC of that drug when tested alone, the interaction was termed synergistic. If [30%]) than with sulfamethoxazole-trimethoprim and gentamicin (3 of 
